Detail
Article
Online article
FT
Medvik - BMC
  • Something wrong with this record ?

Alzheimer's Disease as a Membrane Dysfunction Tauopathy? New Insights into the Amyloid Cascade Hypothesis

T. Olejar, N. Jankovska, R. Matej

. 2024 ; 25 (17) : . [pub] 20240907

Language English Country Switzerland

Document type Journal Article, Review

Grant support
00064165 Ministry of Health, Czech Reoublic (Conceptual development of research organization)
00064190 Ministry of Health, Czech Reoublic (Conceptual development of research organization)
NU23-04-00173 Grants Agency of the Ministry of Health

The amyloid cascade hypothesis postulates that extracellular deposits of amyloid β (Aβ) are the primary and initial cause leading to the full development of Alzheimer's disease (AD) with intracellular neurofibrillary tangles; however, the details of this mechanism have not been fully described until now. Our preliminary data, coming from our day-to-day neuropathology practice, show that the primary location of the hyperphosphorylated tau protein is in the vicinity of the cell membrane of dystrophic neurites. This observation inspired us to formulate a hypothesis that presumes an interaction between low-density lipoprotein receptor-related protein 1 (LRP1) and fibrillar aggregates of, particularly, Aβ42 anchored at the periphery of neuritic plaques, making internalization of the LRP1-Aβ42 complex infeasible and, thus, causing membrane dysfunction, leading to the tauopathy characterized by intracellular accumulation and hyperphosphorylation of the tau protein. Understanding AD as a membrane dysfunction tauopathy may draw attention to new treatment approaches not only targeting Aβ42 production but also, perhaps paradoxically, preventing the formation of LRP1-Aβ42.

References provided by Crossref.org

000      
00000naa a2200000 a 4500
001      
bmc24018967
003      
CZ-PrNML
005      
20241024111210.0
007      
ta
008      
241015s2024 sz f 000 0|eng||
009      
AR
024    7_
$a 10.3390/ijms25179689 $2 doi
035    __
$a (PubMed)39273636
040    __
$a ABA008 $b cze $d ABA008 $e AACR2
041    0_
$a eng
044    __
$a sz
100    1_
$a Olejar, Tomas $u Department of Pathology and Molecular Medicine, Third Faculty of Medicine, Charles University and Thomayer Faculty Hospital, 140 59 Prague, Czech Republic $u Department of Pathology, Third Faculty of Medicine, Charles University and University Hospital Kralovske Vinohrady, 100 34 Prague, Czech Republic $1 https://orcid.org/0000000207865029 $7 xx0242541
245    10
$a Alzheimer's Disease as a Membrane Dysfunction Tauopathy? New Insights into the Amyloid Cascade Hypothesis / $c T. Olejar, N. Jankovska, R. Matej
520    9_
$a The amyloid cascade hypothesis postulates that extracellular deposits of amyloid β (Aβ) are the primary and initial cause leading to the full development of Alzheimer's disease (AD) with intracellular neurofibrillary tangles; however, the details of this mechanism have not been fully described until now. Our preliminary data, coming from our day-to-day neuropathology practice, show that the primary location of the hyperphosphorylated tau protein is in the vicinity of the cell membrane of dystrophic neurites. This observation inspired us to formulate a hypothesis that presumes an interaction between low-density lipoprotein receptor-related protein 1 (LRP1) and fibrillar aggregates of, particularly, Aβ42 anchored at the periphery of neuritic plaques, making internalization of the LRP1-Aβ42 complex infeasible and, thus, causing membrane dysfunction, leading to the tauopathy characterized by intracellular accumulation and hyperphosphorylation of the tau protein. Understanding AD as a membrane dysfunction tauopathy may draw attention to new treatment approaches not only targeting Aβ42 production but also, perhaps paradoxically, preventing the formation of LRP1-Aβ42.
650    _2
$a lidé $7 D006801
650    12
$a Alzheimerova nemoc $x metabolismus $x patologie $x etiologie $7 D000544
650    12
$a amyloidní beta-protein $x metabolismus $7 D016229
650    12
$a proteiny tau $x metabolismus $7 D016875
650    12
$a protein 1 související s LDL-receptory $x metabolismus $7 D026503
650    12
$a tauopatie $x metabolismus $x patologie $x etiologie $7 D024801
650    _2
$a buněčná membrána $x metabolismus $7 D002462
650    _2
$a fosforylace $7 D010766
650    _2
$a zvířata $7 D000818
650    _2
$a peptidové fragmenty $x metabolismus $7 D010446
655    _2
$a časopisecké články $7 D016428
655    _2
$a přehledy $7 D016454
700    1_
$a Jankovska, Nikol $u Department of Pathology and Molecular Medicine, Third Faculty of Medicine, Charles University and Thomayer Faculty Hospital, 140 59 Prague, Czech Republic $u Department of Pathology, Third Faculty of Medicine, Charles University and University Hospital Kralovske Vinohrady, 100 34 Prague, Czech Republic $1 https://orcid.org/0000000184222628
700    1_
$a Matej, Radoslav $u Department of Pathology and Molecular Medicine, Third Faculty of Medicine, Charles University and Thomayer Faculty Hospital, 140 59 Prague, Czech Republic $u Department of Pathology, Third Faculty of Medicine, Charles University and University Hospital Kralovske Vinohrady, 100 34 Prague, Czech Republic $u Department of Pathology, First Faculty of Medicine, Charles University and General University Hospital, 128 00 Prague, Czech Republic $1 https://orcid.org/0000000261526343
773    0_
$w MED00176142 $t International journal of molecular sciences $x 1422-0067 $g Roč. 25, č. 17 (2024)
856    41
$u https://pubmed.ncbi.nlm.nih.gov/39273636 $y Pubmed
910    __
$a ABA008 $b sig $c sign $y - $z 0
990    __
$a 20241015 $b ABA008
991    __
$a 20241024111204 $b ABA008
999    __
$a ok $b bmc $g 2201669 $s 1230940
BAS    __
$a 3
BAS    __
$a PreBMC-MEDLINE
BMC    __
$a 2024 $b 25 $c 17 $e 20240907 $i 1422-0067 $m International journal of molecular sciences $n Int J Mol Sci $x MED00176142
GRA    __
$a 00064165 $p Ministry of Health, Czech Reoublic (Conceptual development of research organization)
GRA    __
$a 00064190 $p Ministry of Health, Czech Reoublic (Conceptual development of research organization)
GRA    __
$a NU23-04-00173 $p Grants Agency of the Ministry of Health
LZP    __
$a Pubmed-20241015

Find record

Citation metrics

Loading data ...

Archiving options

Loading data ...